| 000 | 01583 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517001746.0 | ||
| 264 | 0 | _c20150109 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1791-7530 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchneeweiss, Andreas | |
| 245 | 0 | 0 |
_aEfficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancer. _h[electronic resource] |
| 260 |
_bAnticancer research _cNov 2014 |
||
| 300 |
_a6609-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbumins _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOsteonectin _xmetabolism |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aSeitz, Julia | |
| 700 | 1 | _aSmetanay, Katharina | |
| 700 | 1 | _aSchuetz, Florian | |
| 700 | 1 | _aJaeger, Dirk | |
| 700 | 1 | _aBachinger, Andreas | |
| 700 | 1 | _aZorn, Markus | |
| 700 | 1 | _aSinn, Hans-Peter | |
| 700 | 1 | _aMarmé, Frederik | |
| 773 | 0 |
_tAnticancer research _gvol. 34 _gno. 11 _gp. 6609-15 |
|
| 999 |
_c24327198 _d24327198 |
||